Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.
The drug is a generic version of Viatris Inc's Revatio oral suspension.
It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.
(If you have a story in and around Mumbai, you have our ears, be a citizen journalist and send us your story here. )
(To receive our E-paper on WhatsApp daily, please click here. To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)
